Great news!

Yesterday (Thursday), the U.S. House of Representatives passed S. 1674, the Improving Access to Clinical Trials Act. Following last month's passage by the U.S. Senate, the bill now heads to the President's desk to be signed into law.

This bill will allow people with CF to participate in important clinical research without losing their public health coverage. By removing barriers to participation in clinical trials, we can speed the development of promising new CF therapies and get them into the hands of the patients who need them.

The Cystic Fibrosis Foundation identified a significant barrier to participation in clinical trials and worked with Congress to write this common sense legislation.

This momentous achievement, almost five years in the making, would not have been possible without the thousands of letters written, calls made, and meetings held by dedicated CF Advocates like you.



YAY!!!